Modulating physicochemical properties of tetrahydropyridine-2-amine BACE1 inhibitors with electron-withdrawing groups: A systematic study.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
15 Jan 2022
Historique:
received: 03 09 2021
revised: 20 11 2021
accepted: 26 11 2021
pubmed: 18 12 2021
medline: 27 1 2022
entrez: 17 12 2021
Statut: ppublish

Résumé

A common challenge for medicinal chemists is to reduce the pK

Identifiants

pubmed: 34920170
pii: S0223-5234(21)00877-1
doi: 10.1016/j.ejmech.2021.114028
pii:
doi:

Substances chimiques

Amidines 0
Enzyme Inhibitors 0
Pyrrolidines 0
Amyloid Precursor Protein Secretases EC 3.4.-
Aspartic Acid Endopeptidases EC 3.4.23.-
BACE1 protein, human EC 3.4.23.46

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114028

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Frederik J R Rombouts (FJR)

Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium. Electronic address: frombout@its.jnj.com.

Chien-Chi Hsiao (CC)

Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium.

Solène Bache (S)

Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium.

Michel De Cleyn (M)

Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium.

Pauline Heckmann (P)

Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium.

Jos Leenaerts (J)

Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium.

Carolina Martinéz-Lamenca (C)

Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium.

Sven Van Brandt (S)

Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium.

Aldo Peschiulli (A)

Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium.

Ann Vos (A)

Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium.

Harrie J M Gijsen (HJM)

Janssen Research & Development, Turnhoutseweg 30, B-2340, Beerse, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH